The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is one of the Best Small-Cap Growth Stocks to Invest In Now. Recently, on June 4, H.C. Wainwright reiterated a Buy rating on Vanda Pharmaceuticals Inc. (NASDAQ ...

FDA approved BYSANTI (milsaperidone) for Bipolar I manic episodes and Schizophrenia in adults VNDA stock jumped up to 44% after-hours on the news Patent protection runs to 2044, blocking generic ...

Add The Drive (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results The car ...

The DC-based biopharma disputed the FDA’s conclusions regarding the data provided in its supplemental application for Hetlioz and promised to keep pushing for an approval. The FDA has rejected Vanda ...

Once again, Vanda Pharmaceuticals is challenging the FDA in court. This time, the company says the agency failed to give its application for Hetlioz in jet lag disorder a proper hearing after the FDA ...

WASHINGTON, Oct. 14, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today confirmed that it received a second unsolicited, non-binding proposal from Cycle ...

WASHINGTON, March 31, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration ...

WASHINGTON, Dec. 20, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VNDA) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for VGT-1849A, a selective ...

Vanda Pharmaceuticals soars after receiving FDA approval for BYSANTI. But investors are cautioned against chasing the momentum in VNDA shares. Vanda Pharmaceuticals' stock is now hovering around its ...